A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Completed · Phase 1

Conditions studied: Smoking Cessation

In brief

This study will investigate the multiple dose pharmacokinetics, safety, and tolerability of two dose strengths of varenicline in adolescents aged 12 to 16 years who regularly smoke at least three cigarettes per day.

Key facts

Study ID
NCT00463918
Run by
Pfizer
People needed
73
Starts
2007-05-01
Expected to finish
2007-12-01
Last updated by the study team
2008-11-19

Who can join

Age: 12 and older, up to 16. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.